Jinsong Liu

16PUBLICATIONS
114CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|Jun 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

|Jan 13, 2026
Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights.

Allison L Brodsky, Amma Asare, Bryan Fellman

|Sep 05, 2025
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy.

Yibo Dai, Anne Knisely, Mitsutake Yano

|Jul 03, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy.

Yibo Dai, Anne Knisely, Mitsutake Yano

|Mar 03, 2025
IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer.

Anca Chelariu-Raicu, Thanh Chung Vu, Sujanitha Umamaheswaran

Pageof 3

Frequent Collaborators

10 joint publications

Anil K Sood

6 joint publications

Shannon Westin

4 joint publications

Amir A Jazaeri

3 joint publications

Robert C Bast